Prema Cognition and Phoenix Community launch one of largest studies yet into whether healthy habits can help reduce inherited dementia risk.
The world’s biggest N-of-1 experiment is here?
Millions of people already count their daily steps, monitor their sleep, wear continuous glucose monitors and optimize their diets – all in pursuit of healthier, longer lives. However, what happens when those individual self-experiments are brought together into something much bigger?
That’s essentially the premise behind a new research partnership between Prema Cognition and the Phoenix Community. More than 3,000 people who carry the APOE4 gene, the strongest known genetic risk factor for late-onset Alzheimer’s disease, will contribute years’ worth of information about how they live, how they age and, crucially, how their cognition changes over time [1].
It’s an intriguing shift in how science is being done. Rather than recruiting participants who simply show up for scheduled clinic visits, researchers are working with a community that is already deeply invested in tracking its own health. In many ways, it resembles thousands of personal “N-of-1” experiments – where individuals continuously test what works for them – combined into one large dataset that could reveal patterns impossible to see in isolation. If successful, it may also demonstrate the growing scientific value of patient-led communities in accelerating prevention research.
Genes load the gun, but they don’t always pull the trigger
For decades, carrying the APOE4 gene was often viewed as a near-inevitable path toward Alzheimer’s disease. Science has since become more nuanced. While APOE4 significantly increases a person’s risk of developing late-onset Alzheimer’s disease, many people with the gene never develop dementia. That suggests genetics are only part of the picture.
Lifestyle appears to matter, too. Researchers have identified numerous factors associated with dementia risk, including physical inactivity, poor sleep, obesity, diabetes, hypertension and hearing loss. Unlike genes, those factors can be changed.
The question is no longer simply who carries genetic risk. Increasingly, it’s how much that risk can be influenced before symptoms ever appear. That’s the question this new collaboration hopes to answer.
Working with the University of Cambridge Memory Lab, Prema Cognition and the Phoenix Community will follow more than 3,000 APOE4 carriers over time. Participants will regularly complete PREMAZ, a digital cognitive assessment developed with Cambridge researchers, while also recording sleep, exercise, nutrition, metabolic health, biomarkers and other lifestyle measures.
Together, the information will create one of the richest real-world datasets yet, examining how inherited risk and everyday behaviors interact across the aging process.
Could memory tracking become the next wearable metric?
Fitness trackers made heart rate and daily steps part of everyday conversation. Continuous glucose monitors transformed metabolic health into something people could observe in real time. Brain health may be heading in the same direction.
Rather than waiting for noticeable memory problems to appear, PREMAZ is designed to detect subtle changes in memory years before conventional cognitive tests typically identify impairment. Think of it like noticing tiny cracks in a road long before potholes appear. That shift – from measuring damage to monitoring resilience – could prove significant for longevity medicine.
If people routinely track sleep quality because it affects recovery, or resting heart rate because it reflects cardiovascular fitness, it’s not difficult to imagine cognitive performance becoming another health metric people choose to monitor proactively.
From identifying risk to reducing it
The collaboration also reflects a larger evolution taking place across dementia research. Historically, much of the field has focused on identifying who is at greatest genetic risk. Today, attention is increasingly turning toward what those individuals can actually do with that knowledge. The challenge is that clinicians still lack robust, evidence-based guidance.
Medicine already has established prevention strategies for conditions like heart disease, diabetes and osteoporosis. Dementia has yet to reach that point.
“For decades, carrying the Alzheimer’s gene was widely viewed as an inevitable path to dementia. We now know that’s not the case, and there is enormous potential to prevent or delay dementia,” said Dr Julia Cooney, Founder and CEO of Prema Cognition. “Doctors have evidence-based clinical guidelines for preventing heart disease, diabetes, and osteoporosis, yet we have nothing comparable for dementia. We hope to generate the evidence needed to change that.”
The Phoenix Community brings another important dimension to the project: highly engaged participants motivated not simply by personal outcomes, but by contributing to research that could help future generations.
“Our community is deeply committed to prevention. People invest enormous effort into improving their sleep, nutrition, exercise, and overall health because they want to reduce their future risk,” said Kevin Tran, Founder of the Phoenix Community. “This partnership gives us the opportunity not only to monitor cognitive health using one of the most sensitive tests available, but also to contribute to research that could benefit millions of people with APOE4 around the world.”
The future of longevity may be community-powered
Perhaps the most interesting aspect of this study is the people. Longevity has traditionally been portrayed as an individual pursuit: your supplements, your biomarkers, your biological age, your personalized protocol. This partnership suggests the future could be far more collaborative.
When thousands of people continuously collect meaningful health data and willingly contribute it to research, individual optimization begins to generate collective knowledge. Citizen science stops being a niche movement and starts becoming a research engine. That’s a notable development for brain health, where progress has often been slowed by the challenge of studying changes that unfold over decades.
Whether this project ultimately reshapes dementia prevention remains to be seen, but it points toward a future where tracking cognitive health could become as routine as counting steps and where the biggest breakthroughs in longevity don’t come from one perfect experiment, but from thousands of people, each running their own, together.
Photographs courtesy of Prema Cognition
